From the 2006 milestone for RNAi to the advancements in mRNA in 2023 and the miRNA in 2024, there are three Nobel Prizes in Physiology or Medicine awarded to scholars for their work on RNA research. RNA has become the cornerstone of next-generation therapies and vaccines. Yet, turning RNA into drugs and vaccines is no small feat—it took 60 years for mRNA to go from discovery to commercialization, and RNAi needed 20 years to make its pharmaceutical debut.

For decades, RNA research laid the groundwork for transformative medical breakthroughs. But it wasn’t until recent history—when Pfizer/BioNTech and Moderna developed life-saving COVID-19 vaccines in under 12 months—that the world truly grasped its potential. These vaccines not only saved millions of lives but also made “mRNA” a household name.

Today, pharmaceutical giants and CDMOs are riding the wave of RNA-based therapeutics. But how can Taiwan seize the opportunity, overcome challenges, and secure its place in this booming field?

Follow #Globalbio vol. 122 for more insights on RNA innovation!

https://news.gbimonthly.com/tw/magazine/article_show.php?num=73061

#GlobalBio #RNARevolution #mRNABreakthroughs #NextGenMedicine